Introduction
Cancer remains one of the most challenging global health problems, characterized by uncontrolled cellular proliferation, genetic instability, immune evasion, and progressive systemic dysfunction. Despite major advances in modern oncology—such as surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy—limitations such as drug resistance, toxicity, recurrence, and reduced quality of life persist. In this context, traditional medical systems like Ayurveda provide a complementary perspective through the concept of Arbuda, which describes abnormal, persistent, and deep-seated growths resembling neoplastic conditions. Ayurvedic formulations aimed at Arbuda focus on restoring systemic balance, enhancing immunity, detoxifying metabolic waste, and inhibiting abnormal tissue proliferation. Integrating these approaches with modern oncology offers a holistic framework for cancer management.
Ayurvedic concept of Arbuda and disease pathogenesis
In Ayurveda, Arbuda is understood as a chronic, slow-growing, and deeply rooted pathological condition arising from the imbalance of Doshas—particularly Kapha and Vata.
- The condition is further influenced by impaired digestive fire (Agni dushti), leading to the accumulation of toxic metabolic byproducts known as Ama. These toxins obstruct physiological channels (Srotas), disrupt normal tissue metabolism, and promote abnormal cellular growth.
- Unlike the reductionist tumor-centric model in modern oncology, Ayurveda views cancer-like conditions as systemic disorders involving multiple physiological layers, including digestion, metabolism, immunity, and tissue nourishment (Dhatu Poshana). This holistic understanding emphasizes not only disease suppression but also restoration of internal balance.
Key Ayurvedic formulations and medicinal herbs
Ayurvedic management of Arbuda involves the use of polyherbal formulations and Rasayana (rejuvenative) therapies that exhibit immunomodulatory, antioxidant, and cytotoxic properties.
- One of the most widely studied herbs is Curcuma longa (turmeric), whose active compound curcumin has demonstrated antiproliferative, anti-inflammatory, and pro-apoptotic effects in various cancer models. Curcumin modulates key molecular pathways such as NF-κB, STAT3, and PI3K/Akt, which are involved in tumor progression.
- Withania somnifera (Ashwagandha) is another important Rasayana herb known for its adaptogenic and anticancer potential. Withanolides present in Ashwagandha have been shown to induce apoptosis, inhibit angiogenesis, and enhance immune surveillance, making it valuable in supportive cancer care.
- Tinospora cordifolia (Guduchi) plays a crucial role in immunomodulation by enhancing macrophage activity and stimulating natural killer (NK) cell function. It also exhibits antioxidant properties that help reduce oxidative stress, a major contributor to carcinogenesis.
- Classical Ayurvedic formulations such as Triphala—a combination of Terminalia chebula, Terminalia bellirica, and Emblica officinalis—are used for detoxification and gastrointestinal health. Triphala has demonstrated anti-inflammatory and antioxidant effects, along with potential anticancer activity in experimental studies.
Mechanistic correlation with modern oncology
From a modern biomedical perspective, Ayurvedic formulations may act through multiple anticancer mechanisms, including induction of apoptosis, inhibition of cell cycle progression, suppression of angiogenesis, and modulation of immune responses. Additionally, their antioxidant properties help neutralize reactive oxygen species (ROS), thereby reducing DNA damage and genomic instability.
The concept of Ama in Ayurveda can be correlated with metabolic toxins and inflammatory mediators that contribute to tumor microenvironment formation. By reducing Ama, Ayurvedic formulations may help in modulating systemic inflammation and improving metabolic homeostasis, which are critical factors in cancer progression.
Integrative oncology and clinical relevance
Integrative oncology combines conventional cancer therapies with complementary traditional approaches to improve patient outcomes. Ayurvedic formulations may play a supportive role by reducing chemotherapy-induced side effects such as nausea, fatigue, and mucositis, while also enhancing immune function and improving quality of life.
However, clinical integration requires rigorous scientific validation, standardized herbal preparations, and careful monitoring of herb–drug interactions. Personalized approaches based on Prakriti (individual constitution) may further enhance therapeutic precision and efficacy.
Conclusion
Ayurvedic formulations for Arbuda offer a comprehensive and multidimensional approach to cancer management by addressing not only tumor growth but also underlying systemic imbalances. By bridging ancient Ayurvedic wisdom with modern oncology, these formulations provide promising complementary strategies that emphasize immunity, detoxification, and metabolic regulation. Continued research and clinical validation are essential to fully integrate these traditional insights into evidence-based cancer care, paving the way for more holistic and patient-centered oncology practices.1
References:
- Singh D, Varshney S, Varshney AB. Bridging ancient wisdom and modern oncology: Ayurvedic formulations for Arbuda in context of cancer management. J Ayu Int Med Sci. 2025;10(6):149-159. https://jaims.in/jaims/article/view/4401/7551